One harboured an ATM mutation with a second cancer of pancreatic origin; one had a CDK12 mutation but also a second cancer of the liver; the third was initially considered microsatellite stable (by WGS), but following additional analyses on different tissue re-evaluated to be MSI (by both immunohistochemistry and NGS). The gene discussed is ATM; the disease is cancer.